Asahi Kasei Pharma Corp - Company Profile
Powered by 
All the data and insights you need on Asahi Kasei Pharma Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Asahi Kasei Pharma Corp Strategy Report
- Understand Asahi Kasei Pharma Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Asahi Kasei Pharma Corp (Asahi Kasei Pharma), a subsidiary of Asahi Kasei Corp, is a research-based healthcare company that discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. It offers a wide range of specialty pharmaceuticals for various therapeutic areas. The company's portfolio includes prescription drugs and diagnostic products. Asahi Kasei Pharma manufactures and sells branded pharmaceuticals including Teribone, Recomodulin, Reclast, Kevzara, Plaquen, Eril, Famvir, Elcitonin, Flivas, Toledomin, and Bredinin. Its Teribone is a human parathyroid hormone preparation for the treatment of osteoporosis in postmenopausal women at high risk of bone fracture; Recomodulin regulates coagulation through activation of protein C and used to treat the symptoms of disseminated intravascular coagulation (DIC); Elcitonin Injection 20S for pain associated with osteoporosis; Flivas is indicated to treat dysuria accompanying benign prostatic hyperplasia; Flivas decreases urethral pressure and reduces difficulty in urination, and symptoms of nocturia, and incomplete emptying; Bredinin improves the abnormalities in immune function and used for various symptoms such as proteinuria in nephrotic syndrome and lupus nephritis and also reduces pain, joint swelling, and stiffness in rheumatoid arthritis; Eril is a rho-kinase inhibitor that improves cerebral vasospasm and delayed cerebral ischemic symptoms; Reclast, a bisphosphonate agent for the treatment of osteoporosis; Kevzara, a human monoclonal antibody for the treatment of rheumatoid arthritis; and Famvir, an anti-herpes virus agent indicated for the treatment of herpes simplex. The also company develops and manufactures in vitro diagnostic products and enzyme components used in in vitro diagnostic products.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer